{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:51:54Z","timestamp":1792119114689,"version":"4.4.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Hereditary hemochromatosis (HH) occurs due to mutations in the HFE gene. While the C282Y mutation is the most common genotype reported in HH, other genotypes are found less frequently, indicating variable degrees of penetrance. We studied the penetrance of the C282Y\/H63D compound heterozygote genotype in developing clinically significant iron overload.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We have completed a retrospective analysis on every individual within Newfoundland &amp; Labrador who were diagnosed as C282Y\/H63D compound heterozygote between 1996 and 2009 through a molecular genetics study. We collected data for up to 10 years following the initial genotyping using electronic health records, including laboratory values, phlebotomy status, radiologic reports and clinic records. Iron overload status was classified based on the HealthIron study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Between 1996 and 2009, 247 individuals with available health records tested positive for C282Y\/H63D compound heterozygosity. Over the 10 years of our study, 5.3% of patients exhibited iron overload-related disease on the background of documented iron overload. Including these individuals, 10.1% of patients had documented iron overload, 23.1% of patients had a provisional iron overload and the remaining 66.8% of patients had no evidence of iron overload. Only 44 patients had documented phlebotomies, likely based on their severe phenotype at baseline. Despite phlebotomy, the prevalence of iron overload was higher among these patients. The penetrance of compound heterozygosity was also significantly higher among men (P &amp;lt; 0.01).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>C282Y\/H63D compound heterozygosity is a low penetrance genotype in HH. This is the largest reported cohort of C282Y\/H63D compound heterozygotes in North America with an extended follow-up.<\/jats:p><\/jats:sec>","DOI":"10.1093\/jcag\/gwac025","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T12:10:34Z","timestamp":1659010234000},"page":"240-247","source":"Crossref","is-referenced-by-count":11,"title":["C282Y\/H63D Compound Heterozygosity Is a Low Penetrance Genotype for Iron Overload-related Disease"],"prefix":"10.1093","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1942-4669","authenticated-orcid":false,"given":"S M Mahmudul","family":"Hasan","sequence":"first","affiliation":[{"name":"Max Rady College of Medicine, University of Manitoba , Winnipeg, Manitoba , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Farrell","sequence":"additional","affiliation":[{"name":"Discipline of Medicine, Memorial University of Newfoundland, Health Sciences Centre , St. John\u2019s, Newfoundland and Labrador , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Borgaonkar","sequence":"additional","affiliation":[{"name":"Discipline of Medicine, Memorial University of Newfoundland, Health Sciences Centre , St. John\u2019s, Newfoundland and Labrador , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,7,28]]},"reference":[{"key":"2022100308584383800_CIT0001","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1056\/NEJMoa041534","article-title":"Hemochromatosis and iron-overload screening in a racially diverse population","volume":"352","author":"Adams","year":"2005","journal-title":"N Engl J Med"},{"key":"2022100308584383800_CIT0002","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1182\/blood-2014-07-581744","article-title":"How mutant HFE causes hereditary hemochromatosis","volume":"124","author":"Muckenthaler","year":"2014","journal-title":"Blood"},{"key":"2022100308584383800_CIT0003","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ng0896-399","article-title":"A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis","volume":"13","author":"Feder","year":"1996","journal-title":"Nat Genet"},{"key":"2022100308584383800_CIT0004","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1182\/blood.V93.8.2502","article-title":"HFE mutations analysis in 711 hemochromatosis probands: Evidence for S65C implication in mild form of hemochromatosis","volume":"93","author":"Mura","year":"1999","journal-title":"Blood"},{"key":"2022100308584383800_CIT0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1182\/blood-2018-02-830562","article-title":"Phenotypic analysis of hemochromatosis subtypes reveals variations in severity of iron overload and clinical disease","volume":"132","author":"Sandhu","year":"2018","journal-title":"Blood"},{"key":"2022100308584383800_CIT0006","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s10620-006-3210-3","article-title":"Individuals homozygous for the H63D mutation have significantly elevated iron indexes","volume":"51","author":"Samarasena","year":"2006","journal-title":"Dig Dis Sci"},{"key":"2022100308584383800_CIT0007","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1155\/2014\/468521","article-title":"Iron overload is rare in patients homozygous for the H63D mutation","volume":"28","author":"Kelley","year":"2014","journal-title":"Can J Gastroenterol Hepatol"},{"key":"2022100308584383800_CIT0008","doi-asserted-by":"crossref","first-page":"e00258","DOI":"10.14309\/ctg.0000000000000258","article-title":"Clinical penetrance of hereditary hemochromatosis-related end-organ damage of C282Y homozygosity, A newfoundland experience","volume":"11","author":"Lim","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"key":"2022100308584383800_CIT0009","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1182\/blood-2003-10-3564","article-title":"Hemochromatosis mutations in the general population: Iron overload progression rate","volume":"103","author":"Andersen","year":"2004","journal-title":"Blood"},{"key":"2022100308584383800_CIT0010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/hmg\/11.2.185","article-title":"Prevalence of HFE gene C282Y and H63D mutations in a French-Canadian population of neonates and in referred patients","volume":"11","author":"Girouard","year":"2002","journal-title":"Hum Mol Genet"},{"key":"2022100308584383800_CIT0011","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa073286","article-title":"Iron-overload-related disease in HFE hereditary hemochromatosis","volume":"358","author":"Allen","year":"2008","journal-title":"N Engl J Med"},{"issue":"3","key":"2022100308584383800_CIT0012","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/aje\/154.3.193","article-title":"HFE gene and hereditary hemochromatosis: A HuGE review. Human Genome Epidemiology","volume":"154","author":"Hanson","year":"2001","journal-title":"Am J Epidemiol"},{"key":"2022100308584383800_CIT0013","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.cgh.2006.07.009","article-title":"The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis","volume":"4","author":"Walsh","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2022100308584383800_CIT0014","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/hep.22972","article-title":"HFE C282Y\/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity","volume":"50","author":"Gurrin","year":"2009","journal-title":"Hepatology"},{"issue":"4","key":"2022100308584383800_CIT0015","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ajhg.2015.08.008","article-title":"Penetrance of hemochromatosis in HFE genotypes resulting in p.Cys282Tyr and p.[Cys282Tyr];[His63Asp] in the eMERGE network","volume":"97","author":"Gallego","year":"2015","journal-title":"Am J Hum Genet"},{"key":"2022100308584383800_CIT0016","article-title":"Alcohol facts and statistics","volume":"7","author":"NIAA.","year":"2020","journal-title":"Natl Inst Alcohol Abuse Alcohol"},{"key":"2022100308584383800_CIT0017","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/cld.1051","article-title":"Pathology of hepatic iron overload","volume":"17","author":"Salomao","year":"2021","journal-title":"Clin Liver Dis"},{"key":"2022100308584383800_CIT0018","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.14309\/ajg.0000000000000315","article-title":"ACG Clinical Guideline: Hereditary hemochromatosis","volume":"114","author":"Kowdley","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"2022100308584383800_CIT0019","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/archinte.166.3.294","article-title":"Screening for hemochromatosis in asymptomatic subjects with or without a family history","volume":"166","author":"Powell","year":"2006","journal-title":"Arch Intern Med"},{"key":"2022100308584383800_CIT0020","article-title":"HFE p.C282Y homozygosity predisposes to rapid serum ferritin rise after menopause: A genotype-stratified cohort study of hemochromatosis in Australian women","volume":"32","author":"Warne","year":"2017","journal-title":"J Gastroenterol Hepatol (Australia)"},{"key":"2022100308584383800_CIT0021","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00277-010-0901-9","article-title":"Effects of C282Y, H63D, and S65C HFE gene mutations, diet, and life-style factors on iron status in a general Mediterranean population from Tarragona, Spain","volume":"89","author":"Aranda","year":"2010","journal-title":"Ann Hematol"},{"key":"2022100308584383800_CIT0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.endmts.2021.100089","article-title":"The global epidemiology of nonalcoholic steatohepatitis (NASH) and associated risk factors\u2013A targeted literature review","volume":"3","author":"Dufour","year":"2021","journal-title":"Endocr Metab Sci"},{"issue":"1","key":"2022100308584383800_CIT0023","doi-asserted-by":"crossref","first-page":"78","DOI":"10.14218\/JCTH.2014.00037","article-title":"Nonalcoholic fatty liver disease: Dyslipidemia, risk for cardiovascular complications, and treatment strategy","volume":"3","author":"Zhang","year":"2015","journal-title":"J Clin Transl Hepatol"},{"key":"2022100308584383800_CIT0024","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3138\/canlivj-2020-0033","article-title":"A Canadian survey on knowledge of non-alcoholic fatty liver disease among physicians","volume":"4","author":"Sebastiani","year":"2021","journal-title":"Can Liver J"},{"key":"2022100308584383800_CIT0025","doi-asserted-by":"crossref","first-page":"E429","DOI":"10.9778\/cmajo.20190212","article-title":"Burden of nonalcoholic fatty liver disease in Canada, 2019-2030: a modelling study","volume":"8","author":"Swain","year":"2020","journal-title":"CMAJ Open"},{"key":"2022100308584383800_CIT0026","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3138\/canlivj-2021-0002","article-title":"Elevated serum ferritin in non-alcoholic fatty liver disease is not predictive of fibrosis","volume":"5","author":"Trasolini","year":"2022","journal-title":"Can Liver J"},{"issue":"1","key":"2022100308584383800_CIT0027","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jhep.2010.03.001","article-title":"EASL clinical practice guidelines for HFE hemochromatosis","volume":"53","author":"European Association for the Study of the Liver.","year":"2010","journal-title":"J Hepatol"}],"container-title":["Journal of the Canadian Association of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcag\/article-pdf\/5\/5\/240\/46239457\/gwac025.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcag\/article-pdf\/5\/5\/240\/46239457\/gwac025.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T02:23:36Z","timestamp":1700879016000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcag\/article\/5\/5\/240\/6651012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,28]]},"references-count":27,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,7,28]]},"published-print":{"date-parts":[[2022,10,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jcag\/gwac025","relation":{},"ISSN":["2515-2084","2515-2092"],"issn-type":[{"value":"2515-2084","type":"print"},{"value":"2515-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,10,1]]},"published":{"date-parts":[[2022,7,28]]}}}